Millets Pharmaceuticals Private Limited
About Millets Pharmaceuticals Private Limited
Data last updated:
Millets Pharmaceuticals Private Limited is a private limited company based in Jammu, Jammu And Kashmir, India. It operates in the service-based operations segment of the services sector. It was incorporated on 05 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U93090JK2018PTC010477. Its GSTIN is 01AALCM8864A1ZL (Jammu and Kashmir).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Archana Wazir and Om Parkash Raina.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No – 50 Near Ram Temple Keran Ban Talab, Jammu, Jammu and Kashmir, India – 181123.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.66 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹26,294 (net margin 3%) and EBITDA of ₹54,403 (EBITDA margin 6.3%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 50% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No – 50 Near Ram Temple Keran Ban Talab, Jammu, Jammu and Kashmir, India – 181123
- IndustryService, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Millets Pharmaceuticals Private Limited
The main business activity of Millets Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Millets Pharmaceuticals Private Limited FY 2025 filings available
Millets Pharmaceuticals Private Limited reported revenue of ₹8.66 Lakh (up 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Millets Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 50% over five years, including 6% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Millets Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹54,403 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹26,294 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Millets Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Millets Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Millets Pharmaceuticals Private Limited
Millets Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MBM Pharmaceuticals Private Limited | ₹8.7 Lakh (FY 2025) | •••• | •••• | 32.0% | •••• | Akola, Maharashtra, India |
| Domcain Pharmaceuticals Private Limited | ₹8.69 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Chennai, Tamil Nadu, India |
| Litman Pharmaceuticals Private Limited | ₹8.68 Lakh (FY 2024) | •••• | •••• | 59.0% | •••• | Bangalore, Karnataka, India |
| Delvizant Pharmaceuticals Private Limited | ₹8.67 Lakh (FY 2022) | •••• | •••• | -21.0% | •••• | Lucknow, Uttar Pradesh, India |
| Orka Pharmaceuticals Private Limited | ₹8.66 Lakh (FY 2024) | •••• | •••• | 498.0% | •••• | Ahmedabad, Gujarat, India |
| Millets Pharmaceuticals Private Limited this company | ₹8.66 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Jammu, Jammu And Kashmir, India |
| Hysiac Pharmaceuticals Private Limited | ₹8.66 Lakh (FY 2024) | •••• | •••• | -22.0% | •••• | Perinthalmanna, Kerala, India |
| Mobka Pharmaceuticals Private Limited | ₹8.64 Lakh (FY 2025) | •••• | •••• | 30.0% | •••• | Jodhpur, Rajasthan, India |
| Lifeboon Pharmaceuticals Private Limited | ₹8.64 Lakh (FY 2024) | •••• | •••• | 26.0% | •••• | Kanpur, Uttar Pradesh, India |
| Vagakem Pharmaceuticals Private Limited | ₹8.64 Lakh (FY 2024) | •••• | •••• | -8.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Proctus Pharmaceuticals Private Limited | ₹8.62 Lakh (FY 2025) | •••• | •••• | -79.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Millets Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Millets Pharmaceuticals Private Limited
Millets Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Wazir | Director | 05 Jun 2018 | 8 Years 4 Months | Current |
| Om Parkash Raina | Director | 05 Jun 2018 | 8 Years 4 Months | Current |
Ownership and Shareholding of Millets Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Millets Pharmaceuticals Private Limited
Millets Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Millets Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Millets Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Millets Pharmaceuticals Private Limited
Millets Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Archana Wazir was appointed as Director on 05 Jun 2018.
Credit Ratings, Litigation & Regulatory Alerts for Millets Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Millets Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Millets Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Millets Pharmaceuticals Private Limited
Millets Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AALCM8864A1ZL | Jammu and Kashmir | Active | 25 Aug 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Millets Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Millets Pharmaceuticals Private Limited
Millets Pharmaceuticals is an active private limited company based in Jammu, Jammu And Kashmir, India. The company works in other services, within the service industry. It was incorporated on 05 June 2018 (8+ years old) and is registered under CIN U93090JK2018PTC010477.
Millets Pharmaceuticals reported revenue of ₹8.66 Lakh for FY 2024 (up 6% YoY).
Millets Pharmaceuticals has 2 current directors:
- Archana Wazir - Director
- Om Parkash Raina - Director
Millets Pharmaceuticals reported a net profit of ₹26,294 (net margin 3%) and EBITDA of ₹54,403 (EBITDA margin 6.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Millets Pharmaceuticals is 10% over three years and 50% over five years. In the latest year (FY 2024) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Millets Pharmaceuticals is 01AALCM8864A1ZL, registered in Jammu and Kashmir.
The CIN (Corporate Identification Number) of Millets Pharmaceuticals is U93090JK2018PTC010477. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Millets Pharmaceuticals was incorporated on 05 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Jammu.
The peers of Millets Pharmaceuticals by revenue are MBM Pharmaceuticals Private Limited, Domcain Pharmaceuticals Private Limited, Litman Pharmaceuticals Private Limited, Delvizant Pharmaceuticals Private Limited, Orka Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Archana Wazir was appointed as Director on 05 Jun 2018. Om Parkash Raina was appointed as Director on 05 Jun 2018.
The registered office of Millets Pharmaceuticals is at H.No – 50 Near Ram Temple Keran Ban Talab, Jammu, Jammu and Kashmir, India – 181123.